Clinail Nail Lacquer

Indicated for the treatment of dermatophyte-induced dermatomycoses such as Tinea Pedis (athlete's foot) Tinea cruris (Jock itch) Tinea Corporis (Ringworm) Tinea Versicolor (Pityriasis Versicolor) Onychomycosis (a fungal nail infection)

A thin layer should be applied to the affected skin once daily following cleansing (in the evening)and rub in gently and completely. Tinea pedis (athlete's foot): 2-4 weeks Tinea cruris (jock itch): 2-4 weeks Tinea corporis (ringworm): 2-4 weeks Tinea versicolor (pityriasis versicolor): 2 weeks Onychomycosis (fungal nail infection): 6-12 months.

The treatment should be continued uninterrupted until clinical cure.Keep using it for 3 to 5 days after the symptoms of the infection have cleared up to prevent it from coming back.

Current clinical experience does not provide specific dosage recommendations for children.

No interaction found

Must not be reused by patients who have shown hypersensitivity to the active substance or to any of the excipient should not be used by patients who have open wounds or ulcers on the skin - A history of skin allergies or eczema - A weakened immune system

It is a topical antifungal medication that inhibits the production of ergosterol, a component of the fungal cell membrane. This results in the death of the fungus. It works against a variety of fungi, including dermatophytes, yeasts, and molds. It is also well tolerated and has a low risk of adverse reaction.

Don't get it in your eyes, ears, nose, or mouth. If this occurs, rinse immediately with water. Wash your hands thoroughly after using it. Avoid applying the cream to large areas of skin. Do not apply the cream to broken or irritated skin.

Skin irritation, erythema, pruritus, burning sensation, and hypersensitivity. The majority of side effects do not require medical attention and disappear as your body adjusts to the medication. Consult your doctor if they continue or if you are concerned about them.

Pregnancy: There is no experience with Amorolfine during pregnancy. Amorolfine's systemic absorption during and after topical administration is extremely low, so the risk to the human fetus appears to be negligible. Amorolfine Cream should be avoided during pregnancy unless absolutely necessary.

Lactation: Breast-feeding women should avoid using the cream in the breast area.

If amorolfine cream is applied to the same area of skin as another topical medication, they may interact. This may result in increased side effects or decreased effectiveness of either medication.

Keep the temperature below 30°C, away from light and moisture. Keep out of reach of children.